Altrinsic Global Advisors LLC Macrogenics Inc Transaction History

Altrinsic Global Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $568,400 - $1.18 Million	-70,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$24.69 - $31.6 $246,900 - $316,000	-10,000 Reduced 12.5%	70,000 $1.76 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $52,000 - $291,200	-10,000 Reduced 11.11%	80,000 $2.23 Million
Q1 2020 May 14, 2020	BUY	$4.28 - $12.11 $385,200 - $1.09 Million	90,000 New	90,000 $524,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.